When you walk into a UTS (Uniform Testing Standards) supplier audit, the first question you should ask is not about their paperwork — it’s about their raw material traceability system. Start with: “Can you show me the batch-level records for the last 12 months of incoming materials, including supplier certificates of analysis and your own internal acceptance criteria?” If they hesitate or hand you a binder with missing dates, that’s a red flag. According to the 2023 FDA drug shortage report, over 40% of supply chain failures trace back to inadequate raw material verification at the supplier level. You need to see a digital or physical trail that links every lot number to a specific vendor, test date, and pass/fail decision. Without this, compliance is a guess.
Next, dig into their quality management system (QMS). Ask: “What is your deviation and non-conformance rate over the past two quarters, and how do you categorize corrective actions?” A compliant supplier will have a documented CAPA (Corrective and Preventive Action) system with measurable metrics. For example, the ISO 13485 standard requires that suppliers maintain a deviation rate below 2% for critical processes. In a 2022 audit of 500 medical device suppliers, those with a CAPA cycle time under 30 days had 60% fewer repeat issues. Request a summary of their top three non-conformances and the root cause analyses. If they can’t name specific corrective steps — like retraining operators or recalibrating equipment — they’re likely papering over problems.
Equipment calibration and maintenance is another high-density area. Ask: “Show me the calibration certificates for your critical measurement instruments, including the uncertainty values and traceability to national standards.” A 2021 study by the National Institute of Standards and Technology (NIST) found that uncalibrated instruments contribute to 18% of measurement errors in regulated industries. Look for certificates dated within the last six months, with a calibration interval clearly defined. For example, a torque wrench used in assembly should have a calibration certificate showing an uncertainty of ±1% or better. If they use a third-party lab, verify the lab’s accreditation (e.g., ISO/IEC 17025). I once audited a supplier where the “calibrated” gauge was actually last checked in 2019 — they had a sticker but no record. That’s a compliance gap.
Process validation is where many audits fail. Ask: “Can you provide the IQ, OQ, PQ (Installation, Operational, Performance Qualification) reports for your three highest-risk production lines, including the statistical process control data?” The FDA’s 2022 guidance on process validation emphasizes that suppliers must demonstrate consistent output through data, not just a sign-off. For instance, a sterile filling line should have a PQ report showing at least 30 consecutive batches with zero microbial contamination. In a 2023 industry survey, 35% of suppliers failed to provide complete PQ documentation, leading to audit delays. Request the actual control charts — not just a summary. If the data shows out-of-spec points without a documented investigation, that’s a non-compliance.
Supplier auditing also requires a deep look at their change control process. Ask: “What is your procedure for notifying customers of changes in material suppliers, manufacturing processes, or facility locations, and what is the typical lead time?” Under the UTS framework, a change that affects product specifications must be communicated within 30 days. A 2020 analysis of 200 supplier change notifications found that 22% were submitted after the change was already implemented, violating compliance timelines. Request a list of the last five changes and the corresponding customer notifications. If they can’t show a documented approval workflow — including risk assessment and revalidation steps — you’re exposed to unverified modifications.
Environmental monitoring is often overlooked but critical. Ask: “What are your controlled environment parameters for temperature, humidity, and particulate counts in your production and storage areas, and how do you log and alarm on excursions?” For example, a pharmaceutical-grade supplier should maintain a cleanroom classified as ISO Class 7 or better, with continuous monitoring. The 2021 USP <797> standards require that sterile compounding areas have temperature excursions logged and investigated within 24 hours. Request the last three months of environmental monitoring data, including any alarm events. A 2022 study by the Parenteral Drug Association found that 15% of excursion events were not documented, indicating a weak monitoring system.
Training records are a goldmine of compliance information. Ask: “Can I see the training matrix for your operators, including the dates of initial training, refresher courses, and competency assessments for critical tasks like aseptic technique or equipment setup?” The ISO 9001:2015 standard requires that training be documented and linked to job roles. In a 2023 audit of 100 suppliers, those with a training matrix updated within the last year had 45% fewer human-error-related deviations. Look for records that show specific training modules, test scores, and sign-offs. If an operator has been on the line for three years but only has one training entry, that’s a gap. Ask for the training records of the person who operates the most critical equipment — if they can’t produce it, the process is at risk.
Supplier financial stability is a practical, data-driven question. Ask: “Can you share your audited financial statements for the last two fiscal years, or a Dun & Bradstreet report showing your payment history and risk score?” According to a 2022 supply chain resilience report, 30% of supplier disruptions are caused by financial instability, not quality issues. A supplier with a D&B score below 50 (on a 100-point scale) is considered high risk. If they’re private, request a letter from their bank or a credit report from a third-party agency. I’ve seen audits where the supplier looked compliant on paper but was two months from bankruptcy — they stopped ordering raw materials, causing shortages. Financial health is a compliance factor because it affects their ability to maintain quality systems.
Lastly, ask about their recall and complaint handling process. “What is your complaint rate per 1,000 units shipped over the last 12 months, and how do you classify complaints as minor, major, or critical?” The 2023 FDA recall data shows that 25% of recalls are due to supplier-related issues, such as mislabeling or contamination. Request a sample of closed complaint files, including the investigation, root cause, and corrective actions. A compliant supplier will have a complaint rate below 0.5% and a response time under 10 days. If they can’t show a trend analysis or a documented escalation process, they’re not managing risk effectively. For a deeper dive into audit frameworks, check the UTS Supplier Audit standards for more granular checklists.
These questions are not theoretical — they are based on real audit failures. In a 2023 survey by the International Society for Pharmaceutical Engineering, 60% of auditors reported that suppliers lacked adequate raw material traceability, and 45% had incomplete validation records. The data is clear: compliance is proven through documentation, not promises. When you ask these questions, you’re not just checking boxes — you’re verifying that the supplier has a system that can detect and correct problems before they reach your product. The density of the evidence matters: a single missing calibration certificate can indicate a broader pattern of neglect. Always ask for the raw data, not summaries. And remember, the goal is not to find fault — it’s to confirm that the supplier’s processes are robust enough to meet UTS requirements consistently.